Live Breaking News & Updates on Great Britain Specific

Stay updated with breaking news from Great britain specific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UK Government consults stakeholders on changes to UK REACH | Mayer Brown

On 16 May 2024, the UK Government launched an open consultation seeking stakeholders' views on various government proposals and policy options aimed at facilitating the transition of. ....

United Kingdom , Great Britain , Mayer Brown , United Kingdom Government , Great Britain Specific , Statutory Instrument , Safety Executive , Alternative Transitional Registration , Exit Implementation Period ,

Apply for a licence to market a medicine in the UK


Apply for a licence to market a medicine in the UK
How to license a medicine for sale in the UK, including applications through national and international routes.
From:
Contents
Print this page
This guidance also covers licensing a medicine in Northern Ireland through the centralised, decentralised and mutual recognition European procedures.
Which procedure to follow
There are several routes to obtain a marketing authorisation in the United Kingdom (UK), Great Britain (England, Scotland and Wales) or Northern Ireland. The options available will be determined by the intended market and the type of application. The markets in which each route is applicable are indicated in the following guidance: ....

United Kingdom , Northern Ireland , Great Britain , Canada Health , Committee For Medicinal Products , National Health Service , Regulatory Authority , National Rules Scheme , Department Of Health , European Union , Swiss Agency For Therapeutic Products Of Switzerland , Scottish Medicines Consortium , Food Branch , European Commission , Drug Administration , National Institute Of Heath Research , Council Of Europe , Community Procedures , Health Products , Group For Mutual Recognition , National Institute For Health , Health Research Authority , National Procedure , Health Sciences Authority , Access Consortium , Commission On Human Medicines ,